Novel therapies
Search documents
Teknova to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
Globenewswire· 2026-02-05 21:01
Core Viewpoint - Alpha Teknova, Inc. will report its financial results for Q4 and the full year ended December 31, 2025, on February 26, 2026, after market close [1]. Group 1: Financial Reporting - The financial results announcement is scheduled for February 26, 2026, at the close of market [1]. - A webcast and conference call will be held on the same day at 5:30 p.m. Eastern Time for investors to access the results [2]. Group 2: Company Overview - Teknova has been innovating in the manufacture of critical reagents since 1996, supporting the life sciences industry [3]. - The company offers customizable solutions for various stages of the workflow, aiding in molecular diagnostics, synthetic biology, and emerging therapeutic modalities [3]. - Teknova operates from a 180,000 square feet facility in Hollister, California, designed for efficient production of foundational ingredients for next-generation therapies [3].